Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Make That 2 Biotech Stocks Today: Sabby Management Reveals It Bought Advaxis

Sabby Management, Advaxis: Advaxis, Inc. (NASDAQ:ADXS), a micro-cap biotech development company, has just seen Hal Mintz’s Sabby Management disclose a 6.3% stake. Earlier today, Sabby revealed it has joined Alpha Capital Anstalt in another small biotech player, DARA Biosciences Inc (NASDAQ:DARA). We’ll be watching this situation very closely.


Advaxis recently conducted a public offering of some 6.6 million shares and warrants at prices worth $4 per share of common stock, and $0.001 per warrant. The total gross proceeds after the offering amounted to $26.5 million.

Disclosure: none

Recommended Reading:

Is Icahn’s Case for Apple at $1,250 Flawed?

JHL Capital Ups Stake in Unisys to Above 5%

Hirzel Capital Just Bought More Hawaiian Holdings Stock at $7.40/Share